What is the current annual EBITDA of CHE?

As of today, CHE annual EBITDA is $436.01M

What is 1-year change in CHE annual EBITDA?

CHE annual EBITDA is up +8.01% year-over-year

What is 3-year change in CHE annual EBITDA?

CHE annual EBITDA is up +8.67% over the past 3 years

How far is CHE annual EBITDA from its all-time high?

CHE annual EBITDA is currently at its all-time high

How does CHE annual EBITDA rank versus sector peers?

CHE annual EBITDA is higher than 90.82% of companies in Healthcare sector

When is CHE next annual earnings release?

The next annual earnings release for CHE is on February 25, 2026

What is the current quarterly EBITDA of CHE?

As of today, CHE quarterly EBITDA is $90.98M

What is CHE quarterly EBITDA most recent change?

CHE quarterly EBITDA was up +7.87% on September 30, 2025

What is 1-year change in CHE quarterly EBITDA?

CHE quarterly EBITDA is down -15.94% year-over-year

How far is CHE quarterly EBITDA from its all-time high?

CHE quarterly EBITDA is currently -37.98% below its historical high of $146.70M set on September 30, 1988

How does CHE quarterly EBITDA rank versus sector peers?

CHE quarterly EBITDA is higher than 88.33% of companies in Healthcare sector

When is CHE next earnings release?

The next earnings release for CHE is on February 25, 2026

What is the current TTM EBITDA of CHE?

As of today, CHE TTM EBITDA is $415.61M

What is CHE TTM EBITDA most recent change?

CHE TTM EBITDA was down -3.99% on September 30, 2025

What is 1-year change in CHE TTM EBITDA?

CHE TTM EBITDA is down -2.70% year-over-year

How far is CHE TTM EBITDA from its all-time high?

CHE TTM EBITDA is currently -8.12% below its historical high of $452.36M set on March 31, 2025

How does CHE TTM EBITDA rank versus sector peers?

CHE TTM EBITDA is higher than 89.59% of companies in Healthcare sector

When is CHE next earnings release?

The next earnings release for CHE is on February 25, 2026

CHE EBITDA History & Chart Since 2014

Annual EBITDA

$436.01M$32.32M+8.01%

December 31, 2024

Summary

Current Value: As of today, CHE annual EBITDA is $436.01M, up +8.01% on December 31, 2024
Historical Performance: CHE annual EBITDA is up +8.67% over the past 3 years, and up +37.74% over the past 5 years
All-Time High Comparison: CHE annual EBITDA is currently at its all-time high
3-Year Low Comparison: CHE annual EBITDA is +8.01% above its 3-year low of $403.70M reached on December 31, 2023
Sector Comparison: CHE annual EBITDA is higher than 90.82% of companies in Healthcare sector

EBITDA Chart

Add series to chart

Add series to chart1/6

Performance

CHE Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 24	$436.01M	+8.0%	+8.7%	+37.7%	+181.6%
Quarterly EBITDA	Sep 30, 25	$90.98M	-15.9%	-4.8%	-9.7%	+103.2%
TTM EBITDA	Sep 30, 25	$415.61M	-2.7%	-0.9%	+17.8%	+149.5%
Price	Jan 9, 26	$444.40	-16.5%	-10.0%	-18.9%	+603.6%
PE Ratio	Jan 9, 26	23.50	-12.1%	-21.3%	-16.4%	+32.1%
Annual Revenue	Dec 31, 24	$2.43B	+7.4%	+13.7%	+25.4%	+104.3%
Annual EPS	Dec 31, 24	$19.89	+10.9%	+18.0%	+49.5%	+513.8%
Annual EBIT	Dec 31, 24	$372.96M	+8.8%	+9.0%	+37.5%	+193.8%
Annual Net Income	Dec 31, 24	$302.00M	+10.8%	+12.5%	+37.3%	+307.9%

EBITDA Highs

CHE Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$436.01M	Dec 31, 24	at high
5Y	$436.01M	Dec 31, 24	at high
All	$436.01M	Dec 31, 24	at high

EBITDA Lows

CHE Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$403.70M	Dec 31, 23	+8.0%
5Y	$371.17M	N/A	+17.5%
All	$17.60M	Dec 31, 91	+2377.2%

EBITDA History

Year	Value	Change
2024	$436.01M	+8.0%
2023	$403.70M	-0.7%
2022	$406.36M	+1.3%
2021	$401.22M	+8.1%
2020	$371.17M	+17.3%
2019	$316.55M	+11.2%

Year	Value	Change
2018	$284.55M	+12.9%
2017	$252.03M	+14.2%
2016	$220.75M	-1.1%
2015	$223.29M	+7.8%
2014	$207.22M	-

FAQ

What is the current annual EBITDA of CHE?
As of today, CHE annual EBITDA is $436.01M
What is 1-year change in CHE annual EBITDA?
CHE annual EBITDA is up +8.01% year-over-year
What is 3-year change in CHE annual EBITDA?
CHE annual EBITDA is up +8.67% over the past 3 years
How far is CHE annual EBITDA from its all-time high?
CHE annual EBITDA is currently at its all-time high
How does CHE annual EBITDA rank versus sector peers?
CHE annual EBITDA is higher than 90.82% of companies in Healthcare sector
When is CHE next annual earnings release?
The next annual earnings release for CHE is on February 25, 2026

Quarterly EBITDA

$90.98M$6.64M+7.87%

September 30, 2025

Summary

Current Value: As of today, CHE quarterly EBITDA is $90.98M, up +7.87% on September 30, 2025
Historical Performance: CHE quarterly EBITDA is down -15.94% year-over-year, and down -4.76% over the past 3 years
All-Time High Comparison: CHE quarterly EBITDA is currently -37.98% below its historical high of $146.70M set on September 30, 1988
3-Year Low Comparison: CHE quarterly EBITDA is +7.87% above its 3-year low of $84.34M reached on June 30, 2025
Sector Comparison: CHE quarterly EBITDA is higher than 88.33% of companies in Healthcare sector

Performance

CHE Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 25	$90.98M	+7.9%	-15.9%	-4.8%	-9.7%
Annual EBITDA	Dec 31, 24	$436.01M	–	+8.0%	+8.7%	+37.7%
TTM EBITDA	Sep 30, 25	$415.61M	-4.0%	-2.7%	-0.9%	+17.8%
Price	Jan 9, 26	$444.40	+3.0%	-16.5%	-10.0%	-18.9%
PE Ratio	Jan 9, 26	23.50	+3.0%	-12.1%	-21.3%	-16.4%
Quarterly Revenue	Sep 30, 25	$624.90M	+1.0%	+3.1%	+18.7%	+18.3%
Quarterly EPS	Sep 30, 25	$4.46	+24.9%	-10.8%	+17.9%	+7.8%
Quarterly EBIT	Sep 30, 25	$74.75M	+9.8%	-19.2%	-7.5%	-13.6%
Quarterly Net Income	Sep 30, 25	$64.24M	+22.4%	-15.2%	+12.9%	-5.2%

Quarterly EBITDA Highs

CHE Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$129.50M	N/A	-29.7%
3Y	$129.50M	Dec 31, 24	-29.7%
5Y	$129.50M	Dec 31, 24	-29.7%
All	$146.70M	Sep 30, 88	-38.0%

Quarterly EBITDA Lows

CHE Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$84.34M	Jun 30, 25	+7.9%
3Y	$84.34M	Jun 30, 25	+7.9%
5Y	$84.34M	Jun 30, 25	+7.9%
All	-$311.60M	Dec 31, 88	+129.2%

Quarterly EBITDA History

Month	Value	Change
Sep 2025	$90.98M	+7.9%
Jun 2025	$84.34M	-23.9%
Mar 2025	$110.78M	-14.5%
Dec 2024	$129.50M	+19.6%
Sep 2024	$108.24M	+4.2%
Jun 2024	$103.84M	+17.8%

Month	Value	Change
Mar 2024	$88.14M	-30.6%
Dec 2023	$126.93M	+24.2%
Sep 2023	$102.23M	+20.8%
Jun 2023	$84.65M	-3.4%
Mar 2023	$87.62M	-

FAQ

What is the current quarterly EBITDA of CHE?
As of today, CHE quarterly EBITDA is $90.98M
What is CHE quarterly EBITDA most recent change?
CHE quarterly EBITDA was up +7.87% on September 30, 2025
What is 1-year change in CHE quarterly EBITDA?
CHE quarterly EBITDA is down -15.94% year-over-year
How far is CHE quarterly EBITDA from its all-time high?
CHE quarterly EBITDA is currently -37.98% below its historical high of $146.70M set on September 30, 1988
How does CHE quarterly EBITDA rank versus sector peers?
CHE quarterly EBITDA is higher than 88.33% of companies in Healthcare sector
When is CHE next earnings release?
The next earnings release for CHE is on February 25, 2026

TTM EBITDA

$415.61M$17.26M-3.99%

September 30, 2025

Summary

Current Value: As of today, CHE TTM EBITDA is $415.61M, down -3.99% on September 30, 2025
Historical Performance: CHE TTM EBITDA is down -2.70% year-over-year, and down -0.88% over the past 3 years
All-Time High Comparison: CHE TTM EBITDA is currently -8.12% below its historical high of $452.36M set on March 31, 2025
3-Year Low Comparison: CHE TTM EBITDA is +14.26% above its 3-year low of $363.74M reached on June 30, 2023
Sector Comparison: CHE TTM EBITDA is higher than 89.59% of companies in Healthcare sector

Performance

CHE Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 25	$415.61M	-4.0%	-2.7%	-0.9%	+17.8%
Annual EBITDA	Dec 31, 24	$436.01M	–	+8.0%	+8.7%	+37.7%
Quarterly EBITDA	Sep 30, 25	$90.98M	+7.9%	-15.9%	-4.8%	-9.7%
Price	Jan 9, 26	$444.40	+3.0%	-16.5%	-10.0%	-18.9%
PE Ratio	Jan 9, 26	23.50	+3.0%	-12.1%	-21.3%	-16.4%
TTM Revenue	Sep 30, 25	$2.53B	+0.8%	+6.5%	+18.9%	+22.3%
TTM EPS	Sep 30, 25	$18.91	-2.8%	-4.4%	+9.9%	+14.7%
TTM EBIT	Sep 30, 25	$351.26M	-4.8%	-3.6%	-2.5%	+18.5%
TTM Net Income	Sep 30, 25	$278.81M	-4.0%	-7.6%	+6.4%	+2.8%

TTM EBITDA Highs

CHE TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$452.36M	Mar 31, 25	-8.1%
3Y	$452.36M	Mar 31, 25	-8.1%
5Y	$452.36M	Mar 31, 25	-8.1%
All	$452.36M	Mar 31, 25	-8.1%

TTM EBITDA Lows

CHE TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$415.61M	Sep 30, 25	at low
3Y	$363.74M	Jun 30, 23	+14.3%
5Y	$363.74M	Jun 30, 23	+14.3%
All	-$256.70M	Sep 30, 89	+261.9%

TTM EBITDA History

Month	Value	Change
Sep 2025	$415.61M	-4.0%
Jun 2025	$432.86M	-4.3%
Mar 2025	$452.36M	+5.3%
Dec 2024	$429.72M	+0.6%
Sep 2024	$427.15M	+1.4%
Jun 2024	$421.14M	+4.8%

Month	Value	Change
Mar 2024	$401.96M	+0.1%
Dec 2023	$401.43M	+8.4%
Sep 2023	$370.44M	+1.8%
Jun 2023	$363.74M	-5.8%
Mar 2023	$386.26M	-

FAQ

What is the current TTM EBITDA of CHE?
As of today, CHE TTM EBITDA is $415.61M
What is CHE TTM EBITDA most recent change?
CHE TTM EBITDA was down -3.99% on September 30, 2025
What is 1-year change in CHE TTM EBITDA?
CHE TTM EBITDA is down -2.70% year-over-year
How far is CHE TTM EBITDA from its all-time high?
CHE TTM EBITDA is currently -8.12% below its historical high of $452.36M set on March 31, 2025
How does CHE TTM EBITDA rank versus sector peers?
CHE TTM EBITDA is higher than 89.59% of companies in Healthcare sector
When is CHE next earnings release?
The next earnings release for CHE is on February 25, 2026

EBITDA Formula

EBITDA = + + +

Data Sources & References

CHE Official Website www.chemed.com
Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/19584/000001958425000004/0000019584-25-000004-index.htm
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/19584/000156276225000038/0001562762-25-000038-index.htm
CHE Profile on Yahoo Finance finance.yahoo.com/quote/CHE
CHE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/che